MetaCap

Baird Medical Investment (BDMD) vs iTonic (ITOC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Baird Medical Investment (BDMD) has outperformed iTonic (ITOC) over the past year, losing 54.6% versus a loss of 64.2%. iTonic is the larger company by market cap ($29.4 million vs $25.4 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BDMD-50.31%ITOC-63.00%
+125%+26%-74%
Oct 8, 20251 yearOct 7, 2026
BDMD-92.81%ITOC-93.56%
+684%+277%-131%
Sep 2, 20245 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BDMD versus ITOC key metrics
MetricBDMDITOC
Share price$0.79$4.02
Market cap$25.37M$29.41M
1-day change0.00%-3.13%
YTD return-41.91%-40.32%
1-year return-54.60%-64.16%
Forward P/E5.64—
EPS (TTM)$-0.55$-4.22
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$3.70$18.40
52-week low$0.661$3.42
Distance from 52-week high-78.65%-78.15%
Analyst consensusnone—
Avg. price target upside+406.33%—
Average volume53.21K51.11K
Shares outstanding32.11M6.84M
Employees1467
SectorHealthcareHealthcare
IndustryMedical DevicesMedical Devices

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Baird Medical Investment

BDMD stock →

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation.

Healthcare · Medical Devices · 146 employees

About iTonic

ITOC stock →

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.

Healthcare · Medical Devices · 7 employees

BDMD vs ITOC FAQ

Which is bigger, Baird Medical Investment or iTonic?

iTonic (ITOC) is larger, with a market capitalization of $29.41M compared with $25.37M for Baird Medical Investment (BDMD).

Which stock has performed better over the past year, BDMD or ITOC?

BDMD returned -54.60% over the past 12 months, compared with -64.16% for ITOC (price return, excluding dividends). Past performance does not predict future results.

Are Baird Medical Investment and iTonic in the same industry?

Yes. Both are classified in the Medical Devices industry within the Healthcare sector.

More comparisons